Razi Ingber
Patrimonio netto: 5 M $ in data 30/09/2026
Patrimonio netto: 5 M $ in data 30/09/2026
Razi Ingber currently works at RedHill Biopharma Ltd., as Chief Financial Officer from 2023.
Mr. Ingber also formerly worked at PricewaterhouseCoopers (Israel), as Audit Manager.
Mr. Ingber received his undergraduate degree and graduate degree from Tel-Aviv University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 27/04/2026 | 109.680.000 ( 0,21% ) | 5 M $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| REDHILL BIOPHARMA LTD. | Direttore Finanziario/CFO | 01/05/2023 |
| Società | Posizione | Fine |
|---|---|---|
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Comptroller/Controller/Auditor | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
RedHill Biopharma Ltd.
RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale